How much funding has RVL Pharmaceuticals raised?

RVL Pharmaceuticals has disclosed $5M raised across 1 round.

Where is RVL Pharmaceuticals headquartered?

RVL Pharmaceuticals is headquartered in Bridgewater, US.

RVL Pharmaceuticals

Bridgewater, US · Incorporated in Ireland

Find your way into RVL Pharmaceuticals

284 people in our graph share verified history with the RVL Pharmaceuticals team — schools, employers, funds. One of them is your warm intro.

Karthik Ardhanareeswaranunlockedknows Lori Deo · together at Johnson & Johnson (overlapped)

×11knows the team · via Johnson & Johnson

RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.

Biotech Consumer Healthtech

Founders & leadership

Lori Deo inChief Executive OfficerLori Deo held multiple leadership positions in CPG healthcare and beauty companies before becoming CEO of RVL Pharmaceuticals, with experience spanning revenue management, brand development, and regulatory compliance.

Raymond DouglasHead of Scientific Affairs

Amy ShahinChief Growth Officer

Katerina GembarskiChief Financial Officer

Kristin ComerGeneral Counsel

Jennifer HanlonChief Marketing Officer

Jessica SolomonChief Human Resources Officer

Patrick KaldawyChief Technology Officer

BRIAN MARKISONNamed on SEC filing

GREGORY COWANNamed on SEC filing

JUAN VERGEZNamed on SEC filing

JOAQUIN BENESNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2023

▶$5MraisedAug 2023 · 1 investors · Pharmaceuticals

Rule 506(b)

Officers, directors & promoters on the filing

BRIAN MARKISONExecutive Officer, Director
GREGORY COWANDirector
JUAN VERGEZDirector
JOAQUIN BENESDirector
MICHAEL DEBIASIDirector
ALISA LASKDirector
JAMES SCHAUBExecutive Officer

Offering amount: $5M
Amount sold: $5M
Sales commissions: $812.5K
Placement agents: H.C. WAINWRIGHT & CO., LLC
First sale: Aug 2023
Incorporated: Other, Ireland
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does RVL Pharmaceuticals do?: RVL Pharmaceuticals develops prescription and skincare products for ocular and aesthetic care, including its flagship prescription eye drop Upneeq (oxymetazoline hydrochloride ophthalmic solution) and the Upneeq Reveal Under Eye Complex skincare product. It serves consumers and healthcare providers with tech-enabled access and integrated fulfillment.
How much funding has RVL Pharmaceuticals raised?: RVL Pharmaceuticals has disclosed $5M raised across 1 round.
Where is RVL Pharmaceuticals headquartered?: RVL Pharmaceuticals is headquartered in Bridgewater, US.